ScinoPharm Taiwan, Ltd., a pharmaceutical company, provides active pharmaceutical ingredient (API) development and manufacturing and injectable solutions in Taiwan, rest of Asia, Europe, and the Americas. It offers small molecules, peptide drugs, and steroids; drug products for anticancer, thromboembolic disorders, and osteoporosis; and contract analytical testing, sterile injectables contract manufacturing, and small molecules and peptide contract development and manufacturing organization services. The company was incorporated in 1997 and is headquartered in Tainan City, Taiwan.
Frequently asked questions
What sector does ScinoPharm Taiwan Ltd (1789) operate in?
ScinoPharm Taiwan Ltd belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is ScinoPharm Taiwan Ltd (1789) current stock price?
As of the latest data, ScinoPharm Taiwan Ltd stock price is NT$18.85, with a previous close of NT$18.85.
What is ScinoPharm Taiwan Ltd (1789) current market capitalization?
ScinoPharm Taiwan Ltd market cap is approximately 14.91 billion.
What is ScinoPharm Taiwan Ltd (1789) Earnings Per Share (EPS)?
The trailing EPS is NT$0.13.
What is ScinoPharm Taiwan Ltd (1789) Price-to-Earnings (P/E) ratio?
ScinoPharm Taiwan Ltd current P/E ratio is 145.
What is ScinoPharm Taiwan Ltd (1789) EBITDA?
ScinoPharm Taiwan Ltd EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -65.41 million.
Does ScinoPharm Taiwan Ltd (1789) pay dividends?
No. ScinoPharm Taiwan Ltd does not pay a dividend.
What is ScinoPharm Taiwan Ltd (1789) beta (volatility) score?
ScinoPharm Taiwan Ltd has a beta of 0.438, indicating lower volatility than the overall market.
